Literature DB >> 28550263

Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy.

Annachiara Cagnin1, Sara Mariotto2, Michele Fiorini2, Marina Gaule2, Nicola Bonetto1, Matteo Tagliapietra2, Emanuele Buratti3, Gianluigi Zanusso2, Sergio Ferrari2, Salvatore Monaco2.   

Abstract

A novel neuronal tauopathy, mainly confined to hypothalamus and brainstem tegmentum, has recently been reported in patients with autoantibodies to the neuronal cell-adhesion molecule IgLON5. We describe a patient with anti-IgLON5 syndrome, who presented with dysautonomia and sleep disorder, followed by subacute dementia. Postmortem brain examination disclosed neuronal tau pathology prevailing in the hippocampus, amygdala, and locus coeruleus, in addition to microglial/neuronal TDP-43 pathology, with overexpression of aberrantly phosphorylated forms and neurotoxic truncated fragments, in basal ganglia, nucleus basalis, thalamus, and midbrain. These findings suggest that neurodegeneration in anti-IgLON5 syndrome might also occur via a microglia-triggered non-cell autonomous pathway.

Entities:  

Keywords:  IgLON5; TDP-43 pathology; microglia; non-cell autonomous neurodegeneration; tauopathy

Mesh:

Substances:

Year:  2017        PMID: 28550263     DOI: 10.3233/JAD-170189

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  14 in total

Review 1.  The Sleep Disorder in Anti-lgLON5 Disease.

Authors:  Carles Gaig; Alex Iranzo; Joan Santamaria; Francesc Graus
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

Review 2.  The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.

Authors:  Peter T Nelson; Erin L Abner; Ela Patel; Sonya Anderson; Donna M Wilcock; Richard J Kryscio; Linda J Van Eldik; Gregory A Jicha; Zsombor Gal; Ruth S Nelson; Bela G Nelson; Jozsef Gal; Md Tofial Azam; David W Fardo; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

3.  IgLON5 autoimmunity tested positive in patients with isolated chronic insomnia disease.

Authors:  Zahra Aghelan; Saeed Karima; Mohammad Rasoul Ghadami; Habibolah Khazaie; Fariborz Bahrehmand; Asad Vaisi-Raygani; Seyed Hosein Abtahi; Reza Khodarahmi
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

4.  Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.

Authors:  Carles Gaig; Yaroslau Compta; Anna Heidbreder; Maria J Marti; Maarten J Titulaer; Yvette Crijnen; Birgit Högl; Jan Lewerenz; María Elena Erro; Juan Carlos Garcia-Monco; Pasquale Nigro; Nicola Tambasco; Maja Patalong-Ogiewa; Marcus Erdler; Stefan Macher; Evelyn Berger-Sieczkowski; Romana Höftberger; Christian Geis; Markus Hutterer; Angela Milán-Tomás; Antonio Martin-Bastida; Lydia Lopez Manzanares; Sonia Quintas; Günter U Höglinger; Nora Möhn; Florian Schoeberl; Franziska S Thaler; Gian Maria Asioli; Federica Provini; Giuseppe Plazzi; Koldo Berganzo; Morten Blaabjerg; Norbert Brüggemann; Tarsis Farias; Chen Fei Ng; Caroline Giordana; Alejandro Herrero-San Martín; Lucio Huebra; Katya Kotschet; Herburg Liendl; Teresa Montojo; Carlos Morata; Jesus Perez Perez; Inmaculada Puertas; Thomas Seifert-Held; Caspar Seitz; Mateus Mistieri Simabukuro; Nieves Tellez; Javier Villacieros-Álvarez; Barbara Willekens; Lidia Sabater; Alex Iranzo; Joan Santamaria Cano; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2021-08-11       Impact factor: 11.800

Review 5.  Anti-IgLON 5 Disease.

Authors:  Anna Heidbreder; Konstanze Philipp
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

Review 6.  A New Classification System for IgG4 Autoantibodies.

Authors:  Inga Koneczny
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

7.  Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.

Authors:  Mette Scheller Nissen; Morten Blaabjerg
Journal:  Front Neurol       Date:  2019-10-02       Impact factor: 4.003

Review 8.  Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis.

Authors:  Matthias Boentert
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-27       Impact factor: 5.081

9.  Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives.

Authors:  Matthias Boentert
Journal:  Nat Sci Sleep       Date:  2019-08-09

10.  Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy.

Authors:  Maria Elena Erro; Lidia Sabater; Laura Martínez; María Herrera; Aiora Ostolaza; Iñaki García de Gurtubay; Teresa Tuñón; Francesc Graus; Ellen Gelpi
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.